Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab.

Damuzzo, V; Solito, S; Pinton, L; Carrozzo, E; Valpione, S; Pigozzo, J; Arboretti Giancristofaro, R; Chiarion-Sileni, V; Mandruzzato, S

Damuzzo, V; Solito, S; Pinton, L; Carrozzo, E; Valpione, S; Pigozzo, J; Arboretti Giancristofaro, R; Chiarion-Sileni, V; Mandruzzato, S.

Afiliação

Damuzzo V; Oncology and Immunology Section, Department of Surgery, Oncology and Gastroenterology, University of Padova , Padova, Italy.
Solito S; Oncology and Immunology Section, Department of Surgery, Oncology and Gastroenterology, University of Padova , Padova, Italy.
Pinton L; Oncology and Immunology Section, Department of Surgery, Oncology and Gastroenterology, University of Padova , Padova, Italy.
Carrozzo E; Department of Management and Engineering, University of Padova , Padova, Italy.
Valpione S; Istituto Oncologico Veneto IOV-IRCCS , Padova, Italy.
Pigozzo J; Istituto Oncologico Veneto IOV-IRCCS , Padova, Italy.
Arboretti Giancristofaro R; Department of Civil, Environmental and Architectural Engineering, University of Padova , Padova, Italy.
Chiarion-Sileni V; Istituto Oncologico Veneto IOV-IRCCS , Padova, Italy.
Mandruzzato S; Oncology and Immunology Section, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.

Oncoimmunology ; 5(12): e1249559, 2016.

Article em En | MEDLINE | ID: mdl-28123888

Palavras-chave

Biomarkers; CTLA-4; ipilimumab; melanoma; myeloid-derived suppressor cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google